Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
The appointment is effective from May 01, 2023 for five years
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Subscribe To Our Newsletter & Stay Updated
